High Sierra Technologies Stock Price, News & Analysis
Company Description
High Sierra Technologies (OTC Link: HSTI) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $29.0M.
HSTI stock has gained 460.0% over the past year. Shares last traded at $1.40.
On a trailing twelve-month basis, High Sierra Technologies reported net income of -$324K and diluted earnings per share of $-0.01.
This page provides a comprehensive overview of HSTI stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
High Sierra Technologies (HSTI) stock last traded at $1.40. Over the past 12 months, the stock has gained 460.0%. At a market capitalization of $29.0M, HSTI is classified as a micro-cap stock with approximately 20.9M shares outstanding.
Latest News
High Sierra Technologies has 3 recent news articles. Key topics include acquisition. View all HSTI news →
SEC Filings
Financial Highlights
operating income reached -$238K, and net income was -$324K. Diluted earnings per share stood at $-0.01. The company generated -$220K in operating cash flow. With a current ratio of 0.04, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
HSTI Company Profile & Sector Positioning
High Sierra Technologies (HSTI) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing HSTI often look at related companies in the same sector, including Rubicon Organics (ROMJF), Radnostix, Inc (INIS), Fluent Corp (CNTMF), Avicanna (AVCNF), and 1CM (MILFF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HSTI's relative position within its industry.